Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
30 January 2019 | Story Ruan Bruwer | Photo Varsity Cup
Varsity Cup
Shimlas scrumhalf, Rewan Kruger, played for the Junior Springboks last year and he was also jointly named Junior Player of the Year for the Shimlas alongside Lubabalo Dobela.

A fresh and inexperienced Shimla team, branded as the youngest squad ever, came two log points short of reaching the semi-finals of the Varsity Cup in last season's tournament. Ten of the players in the squad were still U19 last year. The 2018 rugby year proved to be a reconstructive one for the Shimlas after they parted ways with several members of their team in 2017.

After winning three of their first four encounters, including two away fixtures, the Shimlas were set for a spot in the semi-finals, which could possibly have been a home game. The three victories were against the defending champions Tuks by 19-17, 44-24 against Wits, and a 32-27 win over Ikeys.

The Shimlas played a total of 17 matches in 2018, claiming victory in 12. They finished fourth at the University Sport South Africa (USSA) tournament and won the Mangaung Metro league.

Johan Kotze, Shimla captain and prop, was titled ‘Senior Player of the Year’.

In the same breath, Lubabalo Dobela and Rewan Kruger, who both played for the Junior Springboks, were jointly selected as the ‘Junior Players of the Year’.

Vishuis was named the country’s best hostel rugby team for the third consecutive year. They defeated Patria of the North-West University in the finals by 55-29.

The UFS U20 team won all four of their matches in the group stage of the Young Guns competition before they lost to Tuks in the semi-final.

The Kovsie Sevens team won the bowl competition at the USSA tournament and at the Varsity Sevens they ended in 6th position.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept